Entera Bio (ENTX) Short Interest Ratio & Short Volume $1.97 +0.06 (+3.09%) Closing price 03:04 PM EasternExtended Trading$1.97 +0.00 (+0.05%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio Short Interest DataEntera Bio (ENTX) has a short interest of 140,500 shares. This marks a 92.20% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 71,371 shares to cover all short positions.Current Short Interest140,500 sharesPrevious Short Interest73,100 sharesChange Vs. Previous Month+92.20%Dollar Volume Sold Short$304,885.00Short Interest Ratio2.7 Days to CoverLast Record DateApril 30, 2025Outstanding Shares45,452,000 sharesPercentage of Shares Shorted0.31%Today's Trading Volume15,090 sharesAverage Trading Volume71,371 sharesToday's Volume Vs. Average21% Short Selling Entera Bio? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025140,500 shares $304,885.00 +92.2%N/A2.7 $2.17 4/15/202573,100 shares $132,311.00 -2.3%0.2%1.3 $1.81 3/31/202574,800 shares $127,160.00 -13.1%0.2%1.1 $1.70 3/15/202586,100 shares $161,868.00 -13.7%0.3%0.8 $1.88 2/28/202599,800 shares $184,630.00 -4.5%0.3%0.8 $1.85 2/15/2025104,500 shares $253,935.00 +59.5%0.3%0.9 $2.43 1/31/202565,500 shares $143,445.00 -31.6%N/A0.5 $2.19 1/15/202595,800 shares $218,424.00 +102.5%N/A0.7 $2.28 12/31/202447,300 shares $100,276.00 -23.1%N/A0.4 $2.12 12/15/202461,500 shares $132,840.00 -2.4%N/A0.9 $2.16 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 11/30/202463,000 shares $103,320.00 +19.8%N/A0.9 $1.64 11/15/202452,600 shares $90,998.00 +19.0%N/A0.8 $1.73 10/31/202444,200 shares $80,002.00 +9.4%N/A1.4 $1.81 10/15/202440,400 shares $73,124.00 -14.4%N/A1.1 $1.81 9/30/202447,200 shares $89,680.00 +38.4%N/A1.2 $1.90 9/15/202434,100 shares $67,859.00 +27.7%N/A0.7 $1.99 8/31/202426,700 shares $44,589.00 -4.0%N/A0.5 $1.67 8/15/202427,800 shares $44,480.00 +11.7%N/A0.5 $1.60 7/31/202424,900 shares $40,089.00 -51.0%N/A0.3 $1.61 7/15/202450,800 shares $94,996.00 -29.4%N/A0.5 $1.87 6/30/202471,900 shares $132,296.00 -7.2%N/A0.4 $1.84 6/15/202477,500 shares $160,425.00 -15.2%N/A0.4 $2.07 5/31/202491,400 shares $205,650.00 -28.0%N/A0.4 $2.25 5/15/2024127,000 shares $332,740.00 +260.8%N/A0.5 $2.62 4/30/202435,200 shares $68,992.00 -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226,548.00 +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147,294.00 +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11,097.00 +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1,787.50 -95.0%N/A0 $1.38 2/15/202426,100 shares $27,405.00 +715.6%N/A0.3 $1.05 1/31/20243,200 shares $2,655.36 -80.5%N/A0 $0.83 1/15/202416,400 shares $17,876.00 -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37,680.00 +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39,055.50 -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47,919.28 -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50,492.10 +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37,302.08 +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36,500.00 -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43,137.50 +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34,455.50 +89.1%0.2%1.3 $0.69White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 8/31/202326,600 shares $17,822.00 +24.9%0.1%0.8 $0.67 8/15/202321,300 shares $12,782.13 -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29,388.00 +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8,560.76 -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19,145.18 +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4,871.43 -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26,010.40 -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38,043.68 -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37,961.00 -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92,627.80 -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264,712.00 +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187,759.00 +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77,683.20 +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29,059.80 -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29,284.23 -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26,643.00 -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44,603.00 +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35,294.47 -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41,746.20 -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58,458.86 -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115,895.80 +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56,616.00 +160.2%N/A1 $0.84 9/30/202225,900 shares $26,936.00 -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76,209.00 +38.7%N/A1.7 $1.33 8/31/202241,300 shares $55,755.00 -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77,703.00 -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165,482.00 +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109,480.00 -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117,439.00 -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219,191.00 -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319,490.00 +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306,590.00 -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355,250.00 +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345,054.00 -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501,676.00 -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440,628.00 -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439,632.00 +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395,712.00 -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613,262.00 -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851,264.00 +7.4%N/A0 $2.83 12/31/2021280,000 shares $789,600.00 +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797,093.00 +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811,954.00 -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out. 7/30/2021119,300 shares $613,202.00 -33.3%0.6%0 $5.14 7/15/2021178,800 shares $935,124.00 -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259,235.00 -9.4%0.4%0 $3.73 5/28/202176,700 shares $247,741.00 -15.1%0.5%0 $3.23 5/14/202190,300 shares $263,676.00 -57.1%N/A0 $2.92 4/30/2021210,400 shares $715,360.00 +115.6%N/A0 $3.40 4/15/202197,600 shares $321,104.00 +21.1%N/A0 $3.29 3/31/202180,600 shares $265,980.00 -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239,835.00 -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284,830.00 +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185,009.00 -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180,916.00 +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44,990.00 -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52,965.00 +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33,496.00 -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56,116.50 +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41,580.00 +7.4%0.4%0.3 $1.10 10/15/202035,200 shares $40,128.00 -49.9%0.3%0.2 $1.14 9/30/202070,300 shares $87,172.00 +174.6%0.7%0.1 $1.24 9/15/202025,600 shares $28,416.00 -42.3%0.2%0 $1.11 8/31/202044,400 shares $56,832.00 -28.2%0.4%0.1 $1.28 8/14/202061,800 shares $88,992.00 +8.8%0.6%0.1 $1.44 7/31/202056,800 shares $95,992.00 +11.6%0.5%0.1 $1.69 7/15/202050,900 shares $91,111.00 +110.3%0.5%0.1 $1.79 6/30/202024,200 shares $45,254.00 +505.0%0.2%0.3 $1.87 6/15/20204,000 shares $7,440.00 +263.6%0.0%0.1 $1.86 5/29/20201,100 shares $2,200.00 -8.3%0.0%0 $2.00 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 140,500 shares of ENTX short. Learn More on Entera Bio's current short interest. What is a good short interest ratio for Entera Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENTX shares currently have a short interest ratio of 3.0. Learn More on Entera Bio's short interest ratio. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a increase in short interest in April. As of April 30th, there was short interest totaling 140,500 shares, an increase of 92.2% from the previous total of 73,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Entera Bio: Rapport Therapeutics (14.47%), Atai Life Sciences (8.95%), UroGen Pharma Ltd. (10.89%), ORIC Pharmaceuticals, Inc. (15.74%), Mereo BioPharma Group plc (4.79%), Benitec Biopharma Inc. (1.38%), SNDL Inc. (1.43%), Alpha Teknova, Inc. (28.06%), Checkpoint Therapeutics, Inc. (5.89%), Erasca, Inc. (13.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Rapport Therapeutics Short Interest Data Atai Life Sciences Short Interest Data UroGen Pharma Short Interest Data ORIC Pharmaceuticals Short Interest Data Mereo BioPharma Group Short Interest Data Benitec Biopharma Short Interest Data SNDL Short Interest Data Alpha Teknova Short Interest Data Checkpoint Therapeutics Short Interest Data Erasca Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENTX Stock Free ENTX Stock Alerts